FDA Grants Fast-Track Designation To Cannabis Withdrawal Syndrome Drug
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Psychology Today11d
Why Cannabis Use Disorder is on the Rise
Along with this increase, there has been a jump both in ER visits by people of all age groups who have inadvertently taken ...
Study ties marijuana use to increase in schizophrenia
Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, ...
New research continues to link marijuana with schizophrenia. Experts say it's not so simple
“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...
Medical Xpress on MSN10d
Rising cannabis use disorder cases contribute to growing schizophrenia diagnoses
The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...
ConsumerAffairs1d
Study shows more schizophrenia linked to cannabis disorder after legalization
A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...
Monthly Prescribing Reference2d
FDA Grants Fast Track Status to PP-01 for Cannabis Withdrawal Syndrome
The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...
EurekAlert!11d
Contribution of cannabis use disorder to new cases of schizophrenia has almost tripled over the past 17 years
The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...
Researchers Warn: High-Potency Cannabis Linked to Surging Schizophrenia Diagnoses
A study in Ontario found that schizophrenia cases linked to cannabis use disorder have more than doubled since cannabis ...